BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 31158407)

  • 1. Cardiac fibrosis - A short review of causes and therapeutic strategies.
    Hinderer S; Schenke-Layland K
    Adv Drug Deliv Rev; 2019 Jun; 146():77-82. PubMed ID: 31158407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scientific and pharmacological rationale for the treatment of cardiac damage caused by COVID-19.
    Ferrara F; Vitiello A
    Discov Med; 2020; 30(161):155-161. PubMed ID: 33593483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic Insights into Cardiac Fibrosis: From Pathophysiological Mechanisms to Therapeutic Opportunities.
    Qi R; Lin E; Song J; Wang Y; Lin L
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36557919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syndecans in heart fibrosis.
    Lunde IG; Herum KM; Carlson CC; Christensen G
    Cell Tissue Res; 2016 Sep; 365(3):539-52. PubMed ID: 27411689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiomyocytes facing fibrotic conditions re-express extracellular matrix transcripts.
    Heras-Bautista CO; Mikhael N; Lam J; Shinde V; Katsen-Globa A; Dieluweit S; Molcanyi M; Uvarov V; Jütten P; Sahito RGA; Mederos-Henry F; Piechot A; Brockmeier K; Hescheler J; Sachinidis A; Pfannkuche K
    Acta Biomater; 2019 Apr; 89():180-192. PubMed ID: 30862552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular matrix remodeling and cardiac fibrosis.
    Li L; Zhao Q; Kong W
    Matrix Biol; 2018 Aug; 68-69():490-506. PubMed ID: 29371055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin Management of Myocardial Fibrosis and its Mechanisms of Action: A Review.
    Yu Y; Sun J; Wang R; Liu J; Wang P; Wang C
    Am J Chin Med; 2019; 47(8):1675-1710. PubMed ID: 31786946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.
    Frangogiannis NG
    Mol Aspects Med; 2019 Feb; 65():70-99. PubMed ID: 30056242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac fibrosis in the ageing heart: Contributors and mechanisms.
    Lu L; Guo J; Hua Y; Huang K; Magaye R; Cornell J; Kelly DJ; Reid C; Liew D; Zhou Y; Chen A; Xiao W; Fu Q; Wang BH
    Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1():55-63. PubMed ID: 28316086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction.
    Westermann D; Lindner D; Kasner M; Zietsch C; Savvatis K; Escher F; von Schlippenbach J; Skurk C; Steendijk P; Riad A; Poller W; Schultheiss HP; Tschöpe C
    Circ Heart Fail; 2011 Jan; 4(1):44-52. PubMed ID: 21075869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-eating: friend or foe? The emerging role of autophagy in fibrotic diseases.
    Li Y; Liu R; Wu J; Li X
    Theranostics; 2020; 10(18):7993-8017. PubMed ID: 32724454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disintegration of collagen fibrils by Glucono-δ-lactone: An implied lead for disintegration of fibrosis.
    Jayamani J; Ravikanth Reddy R; Madhan B; Shanmugam G
    Int J Biol Macromol; 2018 Feb; 107(Pt A):175-185. PubMed ID: 28866016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylases in cardiac fibrosis: current perspectives for therapy.
    Tao H; Shi KH; Yang JJ; Huang C; Zhan HY; Li J
    Cell Signal; 2014 Mar; 26(3):521-7. PubMed ID: 24321371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor-2 regulates human cardiac myofibroblast-mediated extracellular matrix remodeling.
    Svystonyuk DA; Ngu JM; Mewhort HE; Lipon BD; Teng G; Guzzardi DG; Malik G; Belke DD; Fedak PW
    J Transl Med; 2015 May; 13():147. PubMed ID: 25948488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte-Dependent Regulation of Cardiac Fibrosis.
    Okyere AD; Tilley DG
    Front Physiol; 2020; 11():301. PubMed ID: 32322219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic changes in myocardial matrix and relevance to disease: translational perspectives.
    Li AH; Liu PP; Villarreal FJ; Garcia RA
    Circ Res; 2014 Feb; 114(5):916-27. PubMed ID: 24577970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular imaging of the cardiac extracellular matrix.
    de Haas HJ; Arbustini E; Fuster V; Kramer CM; Narula J
    Circ Res; 2014 Feb; 114(5):903-15. PubMed ID: 24577969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental therapy of cardiac remodeling with quercetin-containing drugs].
    Kuzmenko MA; Pavlyuchenko VB; Tumanovskaya LV; Dosenko VE; Moybenko AA
    Patol Fiziol Eksp Ter; 2013; (2):17-22. PubMed ID: 24000708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.
    Frangogiannis NG
    Circ Res; 2019 Jun; 125(1):117-146. PubMed ID: 31219741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.